Skip to main content
. Author manuscript; available in PMC: 2017 Jul 12.
Published in final edited form as: Exp Lung Res. 2016 Apr;42(3):154–173. doi: 10.3109/01902148.2016.1164263

Figure 3. PMNs and both MDSC populations demonstrated differences between BALBLpsd and BALB strains treated with BHT.

Figure 3

A) PMNs (CD11b+F480Ly6G+) 3 (left) and 6 (right) days following BHT. B) monocyte (m)MDSCs (CD11bhiF480+Ly6G) were identified in both strains with BHT treatment or controls 3 (left) and 6 (right) days following BHT. C) granulocytic (g)MDSCs (CD11bhiF480Ly6G+) were identified in both strains with BHT treatment or controls 3 (left) and 6 (right) days following BHT. Mean ± SEM presented; n = 3; repeated 3 times. *, P<0.05 compared to oil controls; +, p<0.05 compared to BALB mice.